Diseases, Conditions, Syndromes

Synthetic molecule 'kicks and kills' some persistent HIV in mice

Scientists have designed a synthetic molecule that can reactivate dormant human immunodeficiency virus (HIV) in mice and lead to the death of some of the infected cells, according to a study published in PLOS Pathogens.

Cardiology

Improved survival with enhanced prophylaxis plus ART in HIV

(HealthDay)—For patients with advanced HIV who are initiating antiretroviral therapy (ART), enhanced prophylaxis is associated with reduced rates of death at 24 and 48 weeks, according to a study published in the July 20 ...

page 29 from 40